MyFinsight
Home
Blog
About
Proceeds from exercise of
options
$2,332K
(291.93%↑ Y/Y)
Net cash provided by
financing activities
$2,332K
(291.93%↑ Y/Y)
Net decrease in cash
and cash...
-$226,863K
(-327.20%↓ Y/Y)
Canceled cashflow
$2,332K
Proceeds from maturities
and sales of...
$60,000K
Stock-based compensation
$8,238K
(18.65%↑ Y/Y)
Accounts payable and
accrued...
$4,961K
(282.73%↑ Y/Y)
Non-cash lease expense
$277K
(-20.63%↓ Y/Y)
Net amortization of
premiums and discounts on...
-$237K
Depreciation
$44K
(15.79%↑ Y/Y)
Net cash used in
investing activities
-$184,989K
Net cash used in
operating activities
-$44,206K
(17.68%↑ Y/Y)
Canceled cashflow
$60,000K
Canceled cashflow
$13,757K
Purchase of marketable
securities
$244,929K
Net loss
-$55,436K
(13.70%↑ Y/Y)
Purchase of property and
equipment
$60K
Prepaid expenses and
other assets
$1,400K
(129.52%↑ Y/Y)
Accounts payable and
accrued...
-$850K
(-156.70%↓ Y/Y)
Operating lease
liabilities
-$277K
(14.24%↑ Y/Y)
Back
Back
Cash Flow
Bicara Therapeutics Inc. (BCAX)
Bicara Therapeutics Inc. (BCAX)
source: myfinsight.com